logo
Sichuan Exosome Innovation Biological Technology Co., Ltd
english
français
Deutsch
Italiano
Русский
Español
português
Nederlandse
ελληνικά
日本語
한국
中文
العربية
हिन्दी
Türkçe
bahasa indonesia
tiếng Việt
ไทย
বাংলা
فارسی
polski
english
français
Deutsch
Italiano
Русский
Español
português
Nederlandse
ελληνικά
日本語
한국
中文
العربية
हिन्दी
Türkçe
bahasa indonesia
tiếng Việt
ไทย
বাংলা
فارسی
polski

products details

Created with Pixso. Home Created with Pixso. Products Created with Pixso.
Exosome Clinical
Created with Pixso.

Pneumonia Exosome Atomizing Treatment Exosome Clinical For Acute Bronchitis Chronic Bronchitis

Pneumonia Exosome Atomizing Treatment Exosome Clinical For Acute Bronchitis Chronic Bronchitis

Brand Name: xinmixue
Model Number: box
MOQ: negotiable
Price: negotiable
Payment Terms: T/T,negotiable
Supply Ability: No upper limit
Detail Information
Place of Origin:
chengdu china
Certification:
ios9001
Product Type:
Exosome-based Diagnostic Test
Cost:
Affordable
Clinical Validity:
Clinically Validated
Disease-specific:
Pneumonia, Tuberculosis, Bronchitis, Pulmonary Abscess, Chronic Obstructive Pulmonary Disease (COPD), Asthma, Bronchiectasis, Pulmonary Embolism, Pulmonary Hypertension, Idiopathic Pulmonary Fibrosis, Sarcoidosis, Interstitial Pneumonia, Lung Cancer, Pulmo
Detection Method:
Flow Cytometer
Sample Volume:
2ML,5 ML,10ML,50,100ML,500ML
Source:
Stem Cells
Supply Ability:
No upper limit
Highlight:

pneumonia Exosome atomizing treatment

,

Exosome atomizing treatment for acute bronchitis

,

chronic bronchitis Exosome Clinical

Product Description
Pneumonia Exosome Atomizing Treatment
Clinical Solution for Acute and Chronic Bronchitis
Product Overview

Our exosome atomizing fluid is a clinically validated diagnostic test that helps healthcare providers assess patient health status. Designed for use with our specialized Atomizer instrument, it enables precise sample collection and analysis for various respiratory conditions.

Pneumonia Exosome Atomizing Treatment Exosome Clinical For Acute Bronchitis Chronic Bronchitis 0
Key Features
  • Exosome-based diagnostic technology
  • Clinically validated for accuracy and reliability
  • Multiple sample volume options (2ML to 500ML)
  • Flow cytometer detection method
  • Derived from stem cells
  • Affordable without compromising quality
Technical Specifications
Attribute Value
Product Type Exosome-based Diagnostic Test
Detection Method Flow Cytometer
Source Stem Cells
Sample Volume Options 2ML, 5ML, 10ML, 50ML, 100ML, 500ML
Clinical Applications

Our exosome atomizing fluid has demonstrated effectiveness in addressing various lung conditions including:

Pneumonia, Tuberculosis, Bronchitis, Pulmonary Abscess, COPD, Asthma, Bronchiectasis, Pulmonary Embolism, Pulmonary Hypertension, Idiopathic Pulmonary Fibrosis, Sarcoidosis, Interstitial Pneumonia, Lung Cancer

The product contains bioactive substances that support lung tissue repair and regeneration, offering promising therapeutic potential alongside its diagnostic capabilities.

Support & Services

We provide comprehensive support to ensure optimal product performance:

  • Technical assistance and troubleshooting
  • Training and education programs
  • Data analysis and interpretation support
  • Regular software updates and maintenance
  • Customization options for specific clinical needs
Frequently Asked Questions
What is Exosome atomizing fluid?
Our product contains exosomes - extracellular vesicles crucial for cell communication. It's designed for clinical applications including tissue regeneration and respiratory condition management.
How is the fluid administered?
The fluid is atomized into a fine mist for optimal absorption and distribution to affected areas.
Is the product safe?
Yes, our exosomes are derived from human mesenchymal stem cells and undergo rigorous purity and safety testing.
Can it be combined with other treatments?
While compatible with other therapies, we recommend consulting a healthcare professional before combination treatments.
Clinical Benefits

Our exosome atomizing fluid represents a significant advancement in respiratory diagnostics and treatment. By analyzing exosomes in patient samples, healthcare providers gain valuable insights into lung conditions while potentially supporting tissue repair processes.